Actively hiring
Genomics & Genetic Testing
Cell & Gene Therapy
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Backers
3
DvH Ventures, Illumina Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Kytopen is accelerating access to the next generation of cell therapies through scalable genome engineering by solving manufacturing…

Phase Genomics: Fueling Genomic Discovery. CytoTerra® Cytogenetics, ProxiMeta™ Metagenome Deconvolution, Proximo™ Genome Scaffolding.

Co-founded in 2017 by two pioneers in genome editing technology, Qihan Biotech has world-leading capabilities in multiplexable genome…

Syntax Bio is a synthetic biology company programming the next generation of stem cell-derived therapies and organoids.

Waypoint Bio is a biotechnology company pioneering the next generation of cell therapies for solid tumors.

Metagenomi is an in vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for…
News
Broken String Biosciences launches BaseMap ABE to enable genome-wide off-target characterization in base editing therapeutic development
Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today announced the launch of BaseMap ABE. Built on the Company's INDUCE-seq technology, BaseMap ABE exten
Read more
Report
Broken String Biosciences rebrands to reflect strategic evolution as demand grows for unbiased genome-wide off-target analysis
Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today introduced new branding and comprehensive website as part of its strategic repositioning.
Read more
Report
Broken String Biosciences Rebrands to Reflect Strategic Evolution as Demand Grows for Unbiased Genome-wide Off-target Analysis
CAMBRIDGE, England, March 31, 2026--Broken String Biosciences, a biotechnology company enabling gene editing teams to accelerate development of safer, more effective genetic medicines, today introduced new branding and comprehensive website as part of its
Read more
Report
Pro access
Upgrade to see all 7 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

DvH Ventures
Mérieux Equity Partners